WBP1L pseudogene 4 (WBP1LP4)

WBP1L pseudogene 4 (WBP1LP4) is a genomically-encoded pseudogene related to the WBP1L gene, which encodes the WW domain binding protein 1-like, a transmembrane adaptor protein involved in hematopoiesis and regulation of CXCR4 signaling[1][2][3]. As a pseudogene, WBP1LP4 is not believed to encode a functional protein and there is no evidence that it is transcribed or translated under physiological conditions in humans. There are no described biological activities, disease roles, or utility as a therapeutic target for WBP1LP4. Pseudogenes are typically remnants of ancestral genes that have lost their coding potential through mutation and do not perform known molecular or cellular functions[4]. Notes: - There is substantive information available for the parent protein-coding gene, WBP1L (WW domain binding protein 1 like)[1][2][3], but WBP1LP4 specifically refers to a pseudogene and not the functional gene product. - Pseudogenes such as WBP1LP4 are generally excluded from lists of potential drug targets or biological regulators, unless transcribed and shown to have novel biology, which is not the case here. - If you intended to inquire about the parent gene (WBP1L), relevant information is available about its function in hematopoietic stem cell regulation and CXCR4 signaling[1][2][3]. Summary: WBP1LP4 is not a valid therapeutic target, is not a receptor, enzyme, or signaling molecule, and is not used in clinical or research settings for disease association, drug development, or biomarker discovery. The entry appears to be included for genomic annotation purposes only.